Adding to the Sickle Cell Disease Burden: Rising Hydroxyurea Costs Demand Action

Pediatric Blood & Cancer 2026

View at publisher
Authors: Cassandra Rush, Susan Elizabeth Creary, Mara Crabtree, Timothy Crabtree
DOI: 10.1002/1545-5017.70159
Cited by: 0
References: 11

Abstract

The authors declare no conflicts of interest. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Pharmaceutical Economics and Policy Economic and Financial Impacts of Cancer

Publication details

Journal / source
Pediatric Blood & Cancer
Volume
73
Issue
5
Pages
e70159–e70159
Publication date
17 February 2026
Language
EN